87 related articles for article (PubMed ID: 24732058)
1. Inadvertent high-dose therapy with temozolomide in a child with recurrent pontine glioma followed by a rapid clinical response but deteriorated after substitution with low-dose therapy.
Wang ZJ; Altonok D; Sood S; Konski A; Poulik J
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e549-52. PubMed ID: 24732058
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide in the treatment of recurrent malignant glioma.
Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
[TBL] [Abstract][Full Text] [Related]
3. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
Broniscer A; Iacono L; Chintagumpala M; Fouladi M; Wallace D; Bowers DC; Stewart C; Krasin MJ; Gajjar A
Cancer; 2005 Jan; 103(1):133-9. PubMed ID: 15565574
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?
Rizzo D; Scalzone M; Ruggiero A; Maurizi P; Attinà G; Mastrangelo S; Lazzareschi I; Ridola V; Colosimo C; Caldarelli M; Balducci M; Riccardi R
J Chemother; 2015 Feb; 27(2):106-10. PubMed ID: 25466729
[TBL] [Abstract][Full Text] [Related]
5. A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma.
Sharp JR; Bouffet E; Stempak D; Gammon J; Stephens D; Johnston DL; Eisenstat D; Hukin J; Samson Y; Bartels U; Tabori U; Huang A; Baruchel S
Eur J Cancer; 2010 Dec; 46(18):3271-9. PubMed ID: 20656474
[TBL] [Abstract][Full Text] [Related]
6. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
Wen PY
J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
[No Abstract] [Full Text] [Related]
7. [Favourable result for temozolomide in recurrent high-grade glioma].
Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
[TBL] [Abstract][Full Text] [Related]
8. Response to nimotuzumab in a child with a progressive diffuse intrinsic pontine glioma.
Mateos ME; López-Laso E; Izquierdo L; Pérez-Navero JL; García S; Garzás C
Pediatr Int; 2011 Apr; 53(2):261-3. PubMed ID: 21501315
[No Abstract] [Full Text] [Related]
9. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
Reardon DA; Quinn JA; Rich JN; Desjardins A; Vredenburgh J; Gururangan S; Sathornsumetee S; Badruddoja M; McLendon R; Provenzale J; Herndon JE; Dowell JM; Burkart JL; Newton HB; Friedman AH; Friedman HS
Cancer; 2005 Oct; 104(7):1478-86. PubMed ID: 16088964
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma.
Burzynski SR; Janicki TJ; Weaver RA; Burzynski B
Integr Cancer Ther; 2006 Mar; 5(1):40-7. PubMed ID: 16484713
[TBL] [Abstract][Full Text] [Related]
12. Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma.
Broniscer A; Jia S; Mandrell B; Hamideh D; Huang J; Onar-Thomas A; Gajjar A; Raimondi SC; Tatevossian RG; Stewart CF
Pediatr Blood Cancer; 2018 Jul; 65(7):e27035. PubMed ID: 29512900
[TBL] [Abstract][Full Text] [Related]
13. Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours.
Baruchel S; Diezi M; Hargrave D; Stempak D; Gammon J; Moghrabi A; Coppes MJ; Fernandez CV; Bouffet E
Eur J Cancer; 2006 Sep; 42(14):2335-42. PubMed ID: 16899365
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of temozolomide using an extended continuous oral schedule.
Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of temozolomide: could you use temozolomide safely for life in gliomas?
Khasraw M; Bell D; Wheeler H
J Clin Neurosci; 2009 Jun; 16(6):854-5. PubMed ID: 19303779
[TBL] [Abstract][Full Text] [Related]
17. Prolonged administration of temozolomide in adult patients with anaplastic glioma.
Freyschlag CF; Smolczyk DR; Janzen E; Schmieder K; Thomé C; Lohr F; Wenz F; Weiss C; Tuettenberg J; Seiz M
Anticancer Res; 2011 Nov; 31(11):3873-7. PubMed ID: 22110212
[TBL] [Abstract][Full Text] [Related]
18. [Safety and efficacy of three-dimensional conformal radiotherapy combined with temozolomide in treatment of diffuse brainstem gliomas].
Fang HH; Nie Q; Kang JB; Li FM; Cai CL
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):707-9. PubMed ID: 22340055
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide for adult brain stem glioblastoma: case report of a long-term survivor.
Zhang C; Yao Y; Wang Y; Chen Z; Wu J; Mao Y; Zhou L
Int J Neurosci; 2010 Dec; 120(12):787-91. PubMed ID: 20946086
[TBL] [Abstract][Full Text] [Related]
20. [Temozolomide in the treatment of recurrent malignant glioma].
Kobayashi H; Sawamura Y; Ishii N; Murata J; Iwasaki Y
No Shinkei Geka; 2006 Dec; 34(12):1241-7. PubMed ID: 17154070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]